Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study.

Boyle, Jemma M; Hegarty, Gemma; Frampton, Christopher; Harvey-Jones, Elizabeth; Dodkins, Joanna; Beyer, Katharina; George, Gincy; Sullivan, Richard; Booth, Christopher; Aggarwal, Ajay; (2021) Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study. European journal of cancer (Oxford, England : 1990), 155. pp. 136-144. ISSN 0959-8049 DOI: https://doi.org/10.1016/j.ejca.2021.07.001

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.ejca.2021.07.001

Abstract

Share

Download

Filename: 1-s2.0-S0959804921004226-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar